Vendor, Doylestown, PA
Baruch S. Blumberg Institute
UEI NAYCKSJB7F68, CAGE 47W56
1 award and $0 obligated between July 24, 2026 and July 24, 2026, 100% under full and open competition, against 10.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93023C00003Definitive Contract, July 24, 2026, Full and Open Competition, 10 offers | National Institutes of Health NiaidNational Institutes of Health | To Develop an Orally Available Small Molecule Antiviral Drug, with Treatment of Yellow Fever Virus Infection as the Primary Indication.NAICS 541715, PSC AN12 | $0 |
- Places of performance
- Pennsylvania
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 1 across 1 awards